Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation
NCT01040156 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-12-29
Summary
Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.
Conditions
- Systemic Aspergillosis
- Systemic Candidiasis
Sponsors & Collaborators
-
University Children's Hospital Tuebingen
lead OTHER
Principal Investigators
-
Ingo Mueller, M.D. · UCHT
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Allogeneic Hematopoietic Stem Cell Transplantation
NCT00750126 ·Status: UNKNOWN ·Phase: PHASE2
-
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
NCT02120157 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
NCT00013533 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation
NCT03014934 ·Status: UNKNOWN
-
Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
NCT00547235 ·Status: NO_LONGER_AVAILABLE
-
Early Diagnosis and Stem Cell Transplantation for Severe Immunodeficiency Diseases
NCT00613561 ·Status: UNKNOWN ·Phase: PHASE2
-
Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
NCT01487577 ·Status: COMPLETED ·Phase: PHASE2
-
T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation
NCT05471661 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
NCT05457556 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
TPO-Mimetic Use in Children for Hematopoietic Failure
NCT04478227 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL
NCT01423500 ·Status: UNKNOWN ·Phase: PHASE3
-
Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)
NCT04593368 ·Status: UNKNOWN ·Phase: PHASE2
-
Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
NCT01772953 ·Status: COMPLETED ·Phase: PHASE2
-
Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
NCT01010867 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies
NCT00241358 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
NCT00986557 ·Status: UNKNOWN ·Phase: PHASE2
-
Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
NCT00107354 ·Status: COMPLETED ·Phase: PHASE1
-
Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS
NCT02969980 ·Status: COMPLETED ·Phase: PHASE2
-
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
NCT00795886 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Clinical Efficacy and Safety of Tosedostat in MDS
NCT02452346 ·Status: COMPLETED ·Phase: PHASE2
-
T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients
NCT05141058 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation
NCT01959100 ·Status: UNKNOWN ·Phase: PHASE3
-
Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma
NCT07276737 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT05589844 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®
NCT02007356 ·Status: RECRUITING ·Phase: PHASE2